OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q2 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $132,000 | +41.9% | 33,279 | +42.9% | 0.01% | +33.3% |
Q4 2018 | $93,000 | -41.5% | 23,286 | +0.7% | 0.01% | -14.3% |
Q3 2018 | $159,000 | +32.5% | 23,122 | +29.7% | 0.01% | +40.0% |
Q2 2018 | $120,000 | -45.9% | 17,822 | -50.5% | 0.01% | -54.5% |
Q3 2017 | $222,000 | -22.6% | 36,021 | +16.3% | 0.01% | -26.7% |
Q2 2017 | $287,000 | -40.8% | 30,962 | -40.8% | 0.02% | -31.8% |
Q1 2017 | $485,000 | +8.7% | 52,300 | -2.1% | 0.02% | -18.5% |
Q4 2016 | $446,000 | +134.7% | 53,400 | +38.9% | 0.03% | +200.0% |
Q2 2016 | $190,000 | -78.8% | 38,433 | -59.9% | 0.01% | -79.1% |
Q4 2015 | $898,000 | -36.6% | 95,877 | +42.3% | 0.04% | -8.5% |
Q2 2015 | $1,417,000 | -42.9% | 67,399 | +14.1% | 0.05% | -45.3% |
Q1 2015 | $2,480,000 | – | 59,092 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |